Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
3GCREB intestinal decolonization with colistin plus rifaximin
2014-000180-41Phase 2Terminated
- Sponsor
- Universitätsklinikum Freiburg
- Start
- Feb 2015
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of colistin and rifaximin in Intestinal carriage of third-generation cephalosporin-resistant Enterobacteriaceae (2 arms), sponsored by Universitätsklinikum Freiburg. Started Feb 2015; status: terminated.
02
Drugs
colistinrifaximin
03
Conditions
Intestinal carriage of third-generation cephalosporin-resistant Enterobacteriaceae
Beyond the preview
Go deeper on 2014-000180-41.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2014-000180-41.